The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status

Clinical Immunology

Volumn 136, Issue 2, 2010, Pages 302-306

  van der Velden, Walter J F M ^a   Plantinga, Theo S ^a   Feuth, Ton ^a   Donnelly, J Peter ^a   Netea, Mihai G ^a   Blijlevens, Nicole M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Candida; Dectin 1; Graft versus host disease; Single nucleotide polymorphism; Th17

Indexed keywords

DECTIN 1;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CANDIDA; CONTROLLED STUDY; FEMALE; FUNGAL COLONIZATION; HUMAN; INCIDENCE; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CANDIDA; CANDIDIASIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GRAFT VS HOST DISEASE; HUMANS; INCIDENCE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; YOUNG ADULT;

EID: 77954311480     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.04.007     Document Type: Article

References (20)

1. Plantinga T.S., van der Velden W.J.F.M., Ferwerda B., van Spriel A.B., Adema G., Feuth T., Donnelly J.P., Brown G.D., Kullberg B.J., Blijlevens N.M., Netea M.G. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2009, 49(5):724-732. September 1.
2. Weck M.M., Appel S., Werth D., Sinzger C., Bringmann A., Grunebach F., Brossart P. hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 2008, 111(8):4264-4272. April 15.
3. Leibundgut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J. Reis e Sousa. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8(6):630-638. June.
4. Leibundgut-Landmann S., Osorio F., Brown G.D., Sousa Reis e Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 2008, 112(13):4971-4980. December 15.
5. Das R., Chen X., Komorowski R., Hessner M.J., Drobyski W.R. Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease. Blood 2009, 113(10):2352-2362. March 5.
6. Kappel L.W., Goldberg G.L., King C.G., Suh D.Y., Smith O.M., Ligh C., Holland A.M., Grubin J., Mark N.M., Liu C., Iwakura Y., Heller G., van den Brink M.R. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009, 113(4):945-952. January 22.
7. Carlson M.J., West M.L., Coghill J.M., Panoskaltsis-Mortari A., Blazar B.R., Serody J.S. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009, 113(6):1365-1374. February 5.
8. Elmaagacli A.H., Koldehoff M., Landt O., Beelen D.W. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant. 2008, 41(9):821-826. May.
9. Cooke K.R., Olkiewicz K., Erickson N., Ferrara J.L. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J. Endotoxin Res. 2002, 8(6):441-448.
10. Ikeda Y., Adachi Y., Ishii T., Tamura H., Aketagawa J., Tanaka S., Ohno N. Blocking effect of anti-Dectin-1 antibodies on the anti-tumor activity of 1, 3-beta-glucan and the binding of Dectin-1 to 1, 3-beta-glucan. Biol. Pharm. Bull. 2007, 30(8):1384-1389. August.
11. van der Velden W.J.FM., Blijlevens N.M., Maas F.M., Schaap N.P., Jansen J.H., van der Reijden B.A., Feuth T., Dolstra H., Donnelly J.P. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. Bone Marrow Transplant. 2009, February 16.
12. Glucksberg H., Storb R., Fefer A., Buckner C.D., Neiman P.E., Clift R.A., Lerner K.G., Thomas E.D. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18(4):295-304. October.
13. Shulman H.M., Sullivan K.M., Weiden P.L., McDonald G.B., Striker G.E., Sale G.E., Hackman R., Tsoi M.S., Storb R., Thomas E.D. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am. J. Med. 1980, 69(2):204-217. August.
14. Beelen D.W., Elmaagacli A., Muller K.D., Hirche H., Schaefer U.W. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999, 93(10):3267-3275. May 15.
15. Marr K.A., Seidel K., Slavin M.A., Bowden R.A., Schoch H.G., Flowers M.E., Corey L., Boeckh M. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000, 96(6):2055-2061. September 15.
16. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., Ho A.W., Hai J.H., Yu J.J., Jung J.W., Filler S.G., Masso-Welch P., Edgerton M., Gaffen S.L. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 2009, February 9.
17. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 2004, 190(3):624-631. August 1.
18. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8(6):639-646. June.
19. Eyerich K., Foerster S., Rombold S., Seidl H.P., Behrendt H., Hofmann H., Ring J., Traidl-Hoffmann C. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 2008, 128(11):2640-2645. November.
20. van de Veerdonk F.L., Marijnissen R.J., Kullberg B.J., Koenen H.J., Cheng S.C., Joosten I., van den Berg W.B., Williams D.L., Van der Meer J.W., Joosten L.A., Netea M.G. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009, 5(4):329-340. April 23.